Nahed El‐Najjar
Impact in
- Toxicology top 0.5%
- Bioactive Compounds and Antitumor Agents
-
- Nigella sativa pharmacological applications
- Natural Compounds in Disease Treatment
Papers in
-
- Antibiotics Pharmacokinetics and Efficacy 8
- Co-authors
- Hala Gali‐Muhtasib (6 shared papers)Heikki Vuorela (4 shared papers)André Gessner (9 shared papers)Regine Schneider‐Stock (2 shared papers)Matthias Ocker (2 shared papers)Arto Urtti (3 shared papers)Raimo A. Ketola (3 shared papers)Pia Vuorela (2 shared papers)
In The Last Decade
Nahed El‐Najjar
25 papers receiving 983 citations
Peers
Comparison fields: 5 of 103
- Toxicology 290
- Complementary and alternative medicine 357
- Molecular Medicine 85
- Pharmacology 93
- Applied Microbiology and Biotechnology 18
Countries citing papers authored by Nahed El‐Najjar
This map shows the geographic impact of Nahed El‐Najjar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nahed El‐Najjar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nahed El‐Najjar more than expected).
Fields of papers citing papers by Nahed El‐Najjar
This network shows the impact of papers produced by Nahed El‐Najjar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nahed El‐Najjar. The network helps show where Nahed El‐Najjar may publish in the future.
Co-authors
The 25 scholars most cited alongside Nahed El‐Najjar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 229 | |
| 2 | 2011 | 186 | |
| 3 | 2007 | 136 | |
| 4 | 2021 | 51 | |
| 5 | 2013 | 42 | |
| 6 | 2018 | 39 | |
| 7 | 2011 | 37 | |
| 8 | 2010 | 32 | |
| 9 | 2008 | 30 | |
| 10 | 2012 | 29 | |
| 11 | 2017 | 25 | |
| 12 | 2018 | 21 | |
| 13 | 2023 | 21 | |
| 14 | 2022 | 21 | |
| 15 | 2015 | 18 | |
| 16 | 2019 | 16 | |
| 17 | 2017 | 15 | |
| 18 | 2017 | 11 | |
| 19 | 2017 | 10 | |
| 20 | 2022 | 9 |
About Nahed El‐Najjar
Nahed El‐Najjar is a scholar working on Pharmacology, Molecular Biology, Epidemiology, Molecular Medicine and Oncology, having authored 25 papers that have together received 1.0k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (8 papers), Antibiotic Resistance in Bacteria (6 papers), Nigella sativa pharmacological applications (5 papers), Bioactive Compounds and Antitumor Agents (3 papers), Urinary Tract Infections Management (3 papers), Chemotherapy-induced organ toxicity mitigation (3 papers), Pneumonia and Respiratory Infections (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). The work is most often cited by research in Toxicology (290 citations), Complementary and alternative medicine (357 citations), Molecular Medicine (85 citations), Pharmacology (93 citations) and Applied Microbiology and Biotechnology (18 citations). Nahed El‐Najjar has collaborated with scholars based in Germany, Lebanon and Finland. Frequent co-authors include Hala Gali‐Muhtasib, Heikki Vuorela, André Gessner, Regine Schneider‐Stock, Matthias Ocker, Arto Urtti, Raimo A. Ketola, Pia Vuorela, Muktheshwar Gandesiri and Jonathan Jantsch. Their work appears in journals such as Oncology Reports, International Immunopharmacology, Antibiotics, Cancers and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.